Israel (IL)

Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study (2018) Corsonello A, Tap L, Roller-Wirnsberger R, Wirnsberger G, Zoccali C, Kostka T, Guligowska A, et al. Journal article EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency (2018) Schipp C, Schluetermann D, Hoenscheid A, Nabhani S, Hoell J, Oommen PT, Ginzel S, et al. Journal article ZNF341 controls STAT3 expression and thereby immunocompetence (2018) Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, Bulashevska A, et al. Journal article Serum organochlorines and non-Hodgkin lymphoma: A case-control study in Israeli Jews and Palestinians (2018) Klil-Drori AJ, Kleinstern G, Abu Seir R, Choshen-Cohen L, Abdeen Z, Hussein E, Aqel M, et al. Journal article Socioeconomic inequalities in exposure to environmental tobacco smoke in children in Israel (2018) Berman T, Barnett-Itzhaki Z, Axelrod R, Keinan-Boker L, Shimony T, Goldsmith R, Göen T, et al. Journal article Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis (2018) Kürten S, Jackson LJ, Kaye J, Vollmer TL Journal article Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial (2018) Pavel ME, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, et al. Journal article Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial (2018) Pavel M, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, et al. Conference contribution RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK (2018) Elhai M, Distler O, Smith V, Matucci-Cerinic M, Alegre-Sancho JJ, Truchetet ME, Braun-Moscovici Y, et al. Conference contribution Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study (2018) Jaeger VK, Siegert E, Hachulla E, Airo P, Valentini G, Matucci-Cerinic M, Scorza R, et al. Conference contribution